Meta AnalysisID 3094

富含亮氨酸的氨基酸/乳清蛋白补充剂和运动干预对老年人肌肉减少症的影响:随机对照试验的系统评价和Meta分析

CRD42022357780

To examined whether Leucine-enriched amino acid/whey protein supplement and exercise intervention improve muscle strength, mass, and performance in sarcopenic older adults

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
3094
Evidence Id
11652
Core Evidence Id
11652
Source Meta Analysis Id
3045
Herb2 Meta Analysis Id
HBMA003045
Crd Id
CRD42022357780
Title
Effects of Leucine-enriched amino acid/whey protein supplement and exercise intervention on Sarcopenia in older adults: a systematic review and meta-analysis of randomized controlled trials
Review Question
To examined whether Leucine-enriched amino acid/whey protein supplement and exercise intervention improve muscle strength, mass, and performance in sarcopenic older adults
Study Type Included
RCT
Condition Being Studied
The European Working Group on Sarcopenia in Older People (EWGSOP) defines sarcopenia as a muscle disease (muscle failure), and characterized by low muscle strength, low quality and quantity of muscles and impaired physical performance of the elderly. The treatment of choice for sarcopenia is still resistance exercise with nutritional supplementation because no pharmacological agents to treat sarcopenia have not become available yet. Leucine-enriched amino acid or leucine-enriched whey protein is one of the most common interventions for treating sarcopenia in older individuals. Leucine is an essential branched-chain amino acid that it has been shown to modify protein turnover in skeletal muscles by decreasing proteolysis and increasing protein synthesis. However, there is insufficient evidence concerning the effect of Leucine-enriched amino acid/whey protein supplement combined exercise intervention on sarcopenia indices, such as muscle strength, mass and performance.
Participant
Elderly people (over 65 years old) with sarcopenia (Considering the European Working Group on Sarcopenia in Older People I and II criteria).
Animal
Human Disease Modelled
Intervention
A population of sarcopenic elderly people will be intake Leucine-enriched amino acid/whey protein. They also need to perform resistance training or exercise.
Comparator Control
Given a placebo that consisted of an isocaloric or diet. They also need to perform resistance training or exercise.
Main Outcome
Functionality evaluated through Gait speed, Timed-up-and-go test, 6min walk speed and Short physical performance battery Strength evaluated through the Grip strength test and Chair stand test. Muscle quantity evaluated through the Appendicular skeletal muscle mass, Appendicular Skeletal Muscle Mass Index, Muscle mass and Legs muscle mass Nutritional status evaluated through the Weght, BMI, Serum albumin level and mini Nutritional Assessment
Outcome Measure
Additional Outcome
Study Method
Systematic review
Keyword
Aged; Exercise Therapy; Humans; Leucine; Randomized Controlled Trials as Topic; Sarcopenia; Whey Proteins
Contact
Genfa Du [email protected]
Organisational Affiliation
Guangzhou University of Chinese Medicine 12 Airport Road, Guangzhou city, China
Funding Source
the Science and Technology Planning Project of Shenzhen (Grant No. JCYJ20180302144355408 and No. JCYJ20190808100818959)
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2022-09-03
Registration Date
2022-09-14
Anticipated Start Date
2022-09-03
Anticipated Completion Date
2022-10-20
Title Cn
富含亮氨酸的氨基酸/乳清蛋白补充剂和运动干预对老年人肌肉减少症的影响:随机对照试验的系统评价和Meta分析
Title En
Effects of Leucine-enriched amino acid/whey protein supplement and exercise intervention on Sarcopenia in older adults: a systematic review and meta-analysis of randomized controlled trials
Bilingual Status
complete